What is Tectonic Therapeutics's price / book?

Tectonic Therapeutics (TECX) reported price / book of 2.5× in Q1 2026.

How has Tectonic Therapeutics's price / book changed year-over-year?

Tectonic Therapeutics's price / book increased by 129.4% year-over-year, from 1.1× to 2.5×.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Tectonic Therapeutics TECX Price / book

Price / book at other companies

ALN

Alnylam PharmaceuticalsALNY

40.8×-41.2×

Septerna, Inc.SEPN

2.9×—

RegenxbioRGNX

20.5×+19.2×

Gyre Therapeutics, Inc.GYRE

6.3×-4.3×

Opko HealthOPK

0.7×-0.1×

Ginkgo BioworksDNA

0.9×+0.3×

Other financials

Income statement

See full

Operating income-$27.3M-49.2%

Net income-$25.2M-58.7%

EPS (diluted)-$1.34-44.1%

Balance sheet

See full

Cash & equivalents$236.9M-22.8%

Total debt$4.9M+86.1%

Total equity$230.4M-23.5%

Total assets$246.6M-21.7%

Cash flow

See full

Operating cash flow-$18.4M-40.7%

CapEx$19.0K-29.6%

Free cash flow-$18.4M-40.6%

Valuation

See full

Market cap$585.51M+58.3%

Enterprise value$353.51M+438%

Returns & leverage

See full

Return on equity-31.4%—

Debt / equity0×0.0×

Current ratio18.5×-4.4×

Where this comes from

Calculated from Tectonic Therapeutics’s reported figures.

market cap/total stockholders equity=2.5×

Based on the most recent quarter.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tectonic Therapeutics's price / book?: Tectonic Therapeutics (TECX) reported price / book of 2.5× in Q1 2026.
How has Tectonic Therapeutics's price / book changed year-over-year?: Tectonic Therapeutics's price / book increased by 129.4% year-over-year, from 1.1× to 2.5×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.